Rheumatoid factor

Rheumatoid Factor (RF) is an autoantibody—an antibody that mistakenly targets the body’s own tissues rather than external threats. RF attaches to a normal antibody called IgG. When this happens, the two form clusters known as immune complexes, which can settle in joints, blood vessels, or glands. Your immune system then reacts to these complexes, leading to inflammation.

Elevated RF, especially in combination with joint pain, stiffness, or swelling, is highly suggestive of rheumatoid arthritis (RA)—a chronic autoimmune disease where the immune system attacks the synovial lining of the joints. However, RF can also be present in other autoimmune conditions (such as lupus, Sjögren’s syndrome, or mixed connective tissue disease), certain chronic infections, and occasionally in healthy individuals, particularly older adults.

RF is not a standalone diagnostic test; instead, it is interpreted alongside symptoms, inflammatory markers (like CRP and ESR), and other autoantibodies such as anti-CCP antibodies. While high RF levels signal increased autoimmune activity, low or normal levels do not completely rule out RA, since some individuals with RA are "seronegative." Even so, RF remains a central test because it reflects a pattern of immune dysregulation that can be meaningful across several inflammatory and autoimmune conditions.

RF is important because it acts as both a marker of autoimmune activation and a driver of inflammation in rheumatoid arthritis. When immune complexes accumulate in joint tissue, they activate the complement system—a key part of the immune defense network. This sets off a cascade of inflammatory mediators, including cytokines and enzymes, that contribute to joint swelling, cartilage loss, and eventual bone erosion. Over time, this ongoing inflammation can reduce mobility, impair function, and significantly affect quality of life.

However, RF results must be interpreted carefully. Elevated RF does not always mean someone has rheumatoid arthritis. Mild to moderate elevations may occur in systemic lupus erythematosus, Sjögren’s syndrome, sarcoidosis, chronic liver disease, chronic infections, and even some cancers. RF can also appear transiently during acute infections as part of the immune system’s response to immune complexes.

RF has additional relevance in coeliac disease, even though serum RF levels often remain normal. Studies show that people with active coeliac disease can produce RF locally in the intestinal mucosa—reflecting heightened immune activation triggered by gluten exposure in genetically susceptible individuals. This highlights the interconnected nature of autoimmune conditions, where chronic inflammation in one system (gut) may influence immune responses in another (joints).

Understanding your RF level helps clarify whether autoimmune pathways may be contributing to symptoms such as joint pain, persistent fatigue, systemic inflammation, or multi-system involvement.

Dietary and environmental factors

While diet does not directly raise RF, food and environmental triggers that influence overall inflammation can affect autoimmune activity. Diets high in ultra-processed foods, excess omega-6 oils, refined sugars, and alcohol may contribute to systemic inflammation, potentially worsening autoimmune pathways. In contrast, whole-food, anti-inflammatory dietary patterns (rich in fish, nuts, seeds, vegetables, legumes, and polyphenols) may help mitigate inflammatory load.

Lifestyle factors

Smoking is one of the strongest known environmental risk factors for elevated RF and rheumatoid arthritis—especially in individuals with HLA-DRB1 “shared epitope” genes. Smoking enhances the modification of proteins in the lungs, making them appear “foreign” to the immune system and potentially triggering RF production.
Chronic stress, poor sleep, and sedentary behaviour can also influence immune regulation.

Gut microbiome and permeability

Dysbiosis (imbalances in gut bacteria) and increased intestinal permeability expose the immune system to microbial and dietary antigens, making it more reactive. This can contribute to autoimmune cascades seen in both RA and coeliac disease. Certain bacteria, including Prevotella copri, have been associated with early autoimmune activity and heightened inflammation.

Genetics and immune activation

Genetics shape how the immune system responds to environmental triggers. HLA-DRB1 increases susceptibility to RA, while HLA-DQ2/DQ8 increases susceptibility to coeliac disease. In both conditions, heightened immune activity and post-translational modification of proteins (e.g., via PAD enzymes in RA, transglutaminase in coeliac disease) create forms of “altered self” proteins that the immune system may target.

If your RF levels are elevated your clinician will often recommend confirmatory tests, including anti-CCP antibodies, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), to assess the presence and extent of systemic inflammation. Persistent or rising RF levels should be evaluated alongside clinical symptoms such as joint pain, swelling, or stiffness.

For individuals with coeliac disease and joint pain, RF testing can help distinguish whether symptoms are due to gluten-related inflammation or a coexisting autoimmune arthritis. In both cases, modulating autoimmune triggers is central: this includes eliminating gluten in confirmed coeliac disease, avoiding smoking, supporting gut health through anti-inflammatory nutrition, and ensuring adequate levels of vitamin D, omega-3 fatty acids, magnesium, and antioxidants—all of which help regulate immune activity.

While RF itself cannot be “treated,” addressing underlying inflammatory drivers, improving gut barrier integrity, and managing immune stressors can significantly reduce autoimmune burden.

1. McInnes, I. B., & Schett, G. (2011). The pathogenesis of rheumatoid arthritis. The New England Journal of Medicine, 365(23), 2205–2219. https://doi.org/10.1056/NEJMra1004965
   

2. De Leeuw, J., Michiels, B., Derua, R., et al. (2025). Mass spectrometry-based analysis of rheumatoid factor. Frontiers in Immunology, 16, 1644334. https://doi.org/10.3389/fimmu.2025.1644334
   

3. Tan, E. M., & Smolen, J. S. (2016). Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. The Journal of Experimental Medicine, 213(10), 1937–1950. https://doi.org/10.1084/jem.20160792
   

4. Coenen, M. J., Trynka, G., Heskamp, S., et al. (2009). Common and different genetic background for rheumatoid arthritis and coeliac disease. Human Molecular Genetics, 18(21), 4195–4203. https://doi.org/10.1093/hmg/ddp365
   

5. Gravallese, E. M., & Firestein, G. S. (2023). Rheumatoid arthritis — common origins, divergent mechanisms. The New England Journal of Medicine, 388(6), 529–542. https://doi.org/10.1056/NEJMra2103726
   

6. Brandl, C., Bucci, L., Schett, G., & Zaiss, M. M. (2021). Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis. European Journal of Immunology, 51(4), 798–810. https://doi.org/10.1002/eji.202048876
   

7. Catrina, A. I., Deane, K. D., & Scher, J. U. (2016). Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis. Rheumatology (Oxford), 55(3), 391–402. https://doi.org/10.1093/rheumatology/keu469
   

8. Stenberg, P., Roth, B., & Wollheim, F. A. (2009). Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: A reflection of the involvement of transglutaminase in coeliac disease. European Journal of Internal Medicine, 20(8), 749–755. https://doi.org/10.1016/j.ejim.2009.08.007